Nkcfo LLC Invests $1.35 Million in Teladoc Health, Inc. (NYSE:TDOC)

Key Points

• Nkcfo LLC purchased 169,000 shares of Teladoc Health, valued at approximately $1.35 million, representing 0.10% ownership in the company.
• Insider Carlos Nueno sold 3,958 shares of Teladoc Health, decreasing his ownership by 18.32%, while company insiders have collectively sold 18,656 shares worth approximately $128,189 in the past three months.
• Wall Street analysts have mixed opinions on Teladoc Health, with an average rating of "Hold" and an average price target of $9.67, indicating a cautious outlook for the stock.

Nkcfo LLC acquired a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 169,000 shares of the health services provider's stock, valued at approximately $1,345,000. Nkcfo LLC owned 0.10% of Teladoc Health as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Point72 Asset Management L.P. increased its holdings in Teladoc Health by 33.6% in the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock valued at $101,625,000 after buying an additional 2,813,568 shares in the last quarter. Maple Rock Capital Partners Inc. boosted its position in Teladoc Health by 189.5% during the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock worth $32,369,000 after acquiring an additional 2,331,000 shares during the last quarter. Two Sigma Investments LP acquired a new position in Teladoc Health during the fourth quarter worth about $18,348,000. Two Sigma Advisers LP boosted its holdings in Teladoc Health by 213.0% in the 4th quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock valued at $20,532,000 after purchasing an additional 1,537,094 shares during the last quarter. Finally, Vanguard Group Inc. boosted its holdings in Teladoc Health by 5.9% in the 4th quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock valued at $167,830,000 after purchasing an additional 1,029,829 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Price Performance

Shares of TDOC traded down $0.02 during trading hours on Monday, hitting $8.18. 5,046,762 shares of the company were exchanged, compared to its average volume of 6,548,305. The company has a market cap of $1.44 billion, a price-to-earnings ratio of -1.38 and a beta of 1.84. Teladoc Health, Inc. has a fifty-two week low of $6.35 and a fifty-two week high of $15.21. The company has a quick ratio of 1.64, a current ratio of 1.68 and a debt-to-equity ratio of 0.70. The firm's fifty day moving average is $7.68 and its 200 day moving average is $8.55.

Wall Street Analyst Weigh In

TDOC has been the topic of several recent research reports. Evercore ISI upped their target price on shares of Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research note on Wednesday, July 9th. Jefferies Financial Group dropped their price objective on shares of Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. The Goldman Sachs Group dropped their target price on shares of Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. Truist Financial decreased their price target on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a research note on Tuesday, May 27th. Finally, Canaccord Genuity Group decreased their price target on shares of Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a research note on Thursday, May 1st. Thirteen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $9.67.

Insider Activity

In other news, insider Adam C. Vandervoort sold 5,808 shares of the business's stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $39,842.88. Following the completion of the sale, the insider owned 69,773 shares in the company, valued at $478,642.78. The trade was a 7.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Fernando M. Rodrigues sold 4,174 shares of Teladoc Health stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $6.91, for a total value of $28,842.34. The disclosure for this sale can be found here. Over the last three months, insiders have sold 18,656 shares of company stock valued at $128,189. 0.58% of the stock is currently owned by corporate insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.